news
Medicenna's IL-2 super-agonist, MDNA11, successfully induced antitumour cells in animal…
19 October 2021 | By Anna Begley (Drug Target Review)
Medicenna's IL-2 super-agonist, MDNA11, successfully induced antitumour cells in animal models, a pre-clinical study has revealed.